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Dicer is an RNase III enzyme required for processing small regula-
tory RNA, including siRNA and microRNA (miRNA), which respec-
tively originate from exogenous long double-stranded RNA and 
endogenous single-stranded hairpin- or repeat-associated precur-
sors (1–3). siRNA functions by means of perfect or near-perfect base 
pairing with mRNA targets, subsequently guiding mRNA degrada-
tion. miRNA mostly regulates gene expression by imperfect base 
pairing with target mRNA, subsequently guiding mRNA cleavage 
or translational repression (3–5). Mammals have a single Dicer gene, 
which presumably mediates the processing of all miRNA (3).
To determine the role of Dicer in mammals, several groups dis-
rupted the Dicer1 gene in mice and reported that the loss of Dicer1 
resulted in embryonic lethality due to either a loss of pluripotent 
stem cells (6) or impaired angiogenesis in the embryo (7). Tissue-
specific knockouts of Dicer1 have allowed the study of Dicer1’s 
function in selected tissues in adult mice (8–12), but the global 
effect of Dicer1 deficiency has not been addressed. We obtained a 
live Dicer1 hypomorphic expression (Dicerd/d) mouse line using a 
gene-trap method (13), which made it possible to investigate the 
global effect of Dicer1 deficiency in adult mice.
Angiogenesis is the branching and sprouting of capillaries from 
pre-existing blood vessels and is a highly complex process in which 
many factors and cells are involved (14, 15). Although several stud-
ies have reported the involvement of miRNAs in the regulation of 
various molecules required for angiogenesis in vitro (16–19), the 
role of miRNAs in the biology of physiological postnatal angio-
genesis in vivo is incompletely understood because of the lack of 
global miRNA-deficient animal models. In healthy adults, most 
vasculatures are quiescent, except in female reproductive organs. 
The functional corpus luteum (CL), which is formed from the 
ovulated follicle and plays a critical role in the secretion of pro-
gesterone for the maintenance of early pregnancy, requires intense 
angiogenesis (20–22). Although implantation failure has been pro-
posed to explain many cases of recurrent miscarriage in humans 
without knowledge of the exact cause (23), luteal phase insuffi-
ciency is encountered in many of these cases (24–26). The cyclical 
growth of blood vessels associated with the development of the 
ovarian CL is essential for its function and thus for the mainte-
nance of pregnancy (20, 21).
Here we report that live adult Dicer1-deficient female mice are 
infertile. The female infertility in this Dicerd/d mouse line is caused 
by CL insufficiency, which results, at least in part, from an impair-
ment of new capillary vessel growth in the ovary. We further 
show that the impaired CL angiogenesis in Dicerd/d mice is partly 
due to a lack of miR17-5p and let7b, the 2 miRNAs that partici-
pate in the endothelial function of angiogenesis via regulation 
of the expression of the anti-angiogenic factor tissue inhibitor of 
metalloproteinase 1 (TIMP1).
Results
Female mice with hypomorphic Dicer1 expression are sterile. We estab-
lished a hypomorphic Dicer1 expression mouse line using a gene-
trap method (13). The mouse contains a retroviral insertion in 
intron 24 of the Dicer1 gene, which interferes with Dicer1 gene 
expression (13). Despite the fact that the expression of Dicer1 pro-
tein is significantly reduced and miRNA production is diminished 
in this mouse line (13), Dicerd/d mice are viable and healthy with 
apparently normal growth and development. However, whereas 
male Dicerd/d mice were fertile and produced viable offspring, 
Nonstandard	abbreviations	used: CL, corpus luteum; miRNA, microRNA;  
SVEC4-10, simian virus 40-transformed mouse endothelial cells; TIMP1, tissue  
inhibitor of metalloproteinase 1.
Conflict	of	interest: The authors have declared that no conflict of interest exists.
Citation	for	this	article: J. Clin. Invest. 118:1944–1954 (2008). doi:10.1172/JCI33680.
research article
	 The	Journal	of	Clinical	Investigation   http://www.jci.org   Volume 118   Number 5   May 2008 1945
female Dicerd/d mice were completely sterile, regardless of whether 
they mated with Dicerd/d, Dicer+/d, or Dicer+/+ males (Table 1). Repro-
duction in the female mice appears to be very sensitive to the level 
of Dicer1 activity.
Dicer1 deficiency in the ovaries is responsible for infertility in female 
Dicerd/d mice. To determine whether infertility in female Dicerd/d 
mice was due to the gonads or to systemic problems, 
we performed an ovary transplantation (Figure 1A). 
Ovaries from 4-week-old Dicerd/d and Dicer+/+ mice were 
exchanged into the ovarian bursas of each other and 
were subsequently bred to wild-type males. Five of 8 
Dicerd/d mice transplanted with Dicer+/+ ovaries became 
pregnant and delivered pups (average of 3.4 pups/lit-
ter), which were all Dicer+/+, as expected. However, 
none of the Dicer+/+ mice transplanted with Dicerd/d 
ovaries became pregnant, although they showed clear 
vaginal plugs. Because Dicerd/d mice can give birth to 
offspring when transplanted with Dicer+/+ ovaries, 
these results indicated that the cause of the infertility was not a 
systemic problem (e.g., serum factors) or a defect in other parts 
of the reproduction system (e.g., uterus responses), but resulted 
because of a Dicer deficiency in the ovaries.
Luteal insufficiency is the cause of infertility in female Dicerd/d mice. Two 
recent studies reported that the deletion of Dicer1 from growing 
oocytes prevents oocyte maturation (27, 28). We found that our 
mice with hypomorphic Dicer1 expression ovulated normally, and 
their ovulated oocytes were functionally normal in terms of fer-
tilization (Figure 1, B and C). Healthy 2–cell stage embryos can 
be collected from Dicerd/d mice oviducts 1.5 days after coitus (Fig-
ure 1B), which indicates that, unlike the oocytes, in which there 
is a complete deletion of Dicer1, the fertilized oocytes with hypo-
morphic mutant Dicer1 proceed through the first cell division suc-
cessfully. In addition, the number of ovulated eggs and the rate 
of fertilization in Dicerd/d mice were nearly equal to those of their 
wild-type littermates, with or without superovulation induced by 
the administration of pregnant mare serum gonadotropin plus 
human chorionic gonadotropin (Figure 1C).
CL is a transient endocrine gland and is critical to the successful 
maintenance of pregnancy because of its production of proges-
terone. Luteal phase insufficiency leads to female infertility and 
is the cause of such in about 9% of infertile patients (24, 25). The 
main factor associated with luteal phase insufficiency is decreased 
Figure 1
CL insufficiency is the cause of Dicerd/d female mouse 
infertility. (A) Fertility of Dicerd/d female mice transplant-
ed with Dicer+/+ ovaries. Ovaries of Dicerd/d and Dicer+/+ 
littermate mice were exchanged (n = 8 pairs), and the 
mice were subsequently bred to wild-type fertile males. 
Delivery rate and average litter size are shown. (B and C) 
Ovulation and fertilization were normal in Dicerd/d mice. 
(B) Representative morphologies of the 2 cell embryos 
collected from the oviducts of Dicerd/d mice on day 1.5 
after coitus. Original magnification, ×100 (top), ×400 (bot-
tom). (C) Rates of ovulation and fertilization in Dicerd/d 
and Dicer+/+ mice were examined on day 1.5 with or 
without superovulation. (D) Serum progesterone levels 
were lower in Dicerd/d mice during pregnancy. Serum 
levels of progesterone in Dicerd/d mice were determined 
by ELISA on days 1.5, 5.5, and 7.5 of pregnancy and 
expressed as mean ± SD (n = 3). (E) The expression of 
genes associated with CL function was lower in Dicerd/d 
mice. Semiquantitative RT-PCR analyses of luteinizing 
hormone receptor, prolactin receptor, and cytochrome 
P450 family 11 subfamily a polypeptide 1 mRNA in ova-
ries of Dicerd/d and Dicer+/+ mice were conducted on days 
1.5, 5.5, and 7.5 after coitus. Results from 2 separate 
littermate samples are shown.
Table 1
Infertility in female Dicerd/d mice
	 Genotype
Female	 Male	 Mean	litter	size	 No.	of	litters
Dicer+/+ Dicer+/+ 8.4 15
Dicer+/+ Dicer+/d 8.4 5
Dicer+/+ Dicerd/d 7.5 5
Dicer+/d Dicer+/+ 8.1 10
Dicer+/d Dicer+/d 6.5 47
Dicer+/d Dicerd/d 4.0 42
Dicerd/d Dicer+/+ 0 22
Dicerd/d Dicer+/d 0 6
Dicerd/d Dicerd/d 0 10
Number of litters and litter size based on the indicated mating of wild-
type, homozygous, and heterozygous male and female mice.
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progesterone secretion. To examine CL function, serum levels of 
progesterone were measured as a marker of CL function (29) 1.5, 
5.5, and 7.5 days after coitus. As shown in Figure 1D, progesterone 
levels were lower in Dicerd/d mice than in Dicer+/+ mice at all time 
points (Figure 1D). The expression of genes, luteinizing hormone 
receptor, cytochrome P450 family 11 subfamily a polypeptide 1, 
and prolactin receptor, which regulate the formation, function, 
and maintenance of the CL (30), all increased after coitus in wild-
type but not in Dicerd/d mice (Figure 1E). These results suggest that 
the function of CL is impaired in Dicerd/d mice.
Angiogenesis is impaired in the CL of Dicerd/d female mice. Dicer1 is 
required for blood vessel formation and maintenance during 
embryo development (7). The formation of the CL is known to 
be accompanied by a dynamic angiogenesis process that involves 
invasion of a capillary network from the theca tissues into the 
granulosa cell layers (20–22). This led us to hypothesize that the 
defect in ovarian function in 
Dicerd/d mice might be due to the 
impairment of vascular develop-
ment in the CL and to the sub-
sequent insufficient functioning 
of the CL. To examine this pos-
sibility, Dicer+/+ and Dicerd/d mice 
were sacrificed on day 5.5, and 
implantation sites in the uterus 
were examined. None of the 
Dicerd/d mice showed evidence 
of implantation. Histological 
analyses of ovaries obtained on 
day 1.5 showed that the cells in 
the CLs of Dicerd/d mice had less 
cytoplasm and dramatically less 
vascularity within the CLs (Fig-
ure 2A). Ovaries of Dicer+/+ and 
Dicerd/d mice on day 1.5 (a time 
in which an intense vascular net-
work is established in the CL) 
were prepared for immunofluo-
rescent analyses using type IV 
collagen as a marker of the basal 
lamina of endothelial cells (31) 
and other cell layers. As shown 
in Figure 2B, CLs were clearly 
distinguished from surrounding 
follicles by a complex network 
of collagen IV staining in both 
ovaries of Dicer+/+ and Dicerd/d 
mice. However, the collagen 
matrix pattern is clearly different 
between Dicerd/d and Dicer+/+ CLs. 
The filamentous and punctuate 
collagen IV staining in Dicer+/+ 
CLs demonstrated higher ves-
sel densities in Dicer+/+ CLs than 
in Dicerd/d CLs (Figure 2B and 
Supplemental Figure 1; supple-
mental material available online 
with this article; doi:10.1172/
JCI33680DS1). Staining with 
the endothelial marker PECAM1 
(CD31) also showed a decrease in the number and length of the 
vessels in the CLs of Dicerd/d mice (Figure 2C). Quantification of 
the cumulative vessel length in the CLs, determined by counting 
the number and length of the collagen IV staining, revealed fewer 
vessels in the CLs of Dicerd/d mice (Figure 2D). These results sug-
gest that more arborization of the vessels occurred in Dicer+/+ CLs 
than that in Dicerd/d CLs. The growth of new capillary vessels in CLs 
is indeed impaired in Dicerd/d mice.
The antiangiogenic factor TIMP1 is upregulated in Dicerd/d ovaries. 
Dicer1 is unlikely to directly affect angiogenesis but is likely to 
regulate the expression of pro- or antiangiogenesis proteins 
through its processed miRNAs. Several proteins have been impli-
cated as mediators/regulators of CL angiogenesis (22, 32, 33). To 
determine whether the level of any of these proteins was changed 
in Dicerd/d mice, we used mouse angiogenesis antibody arrays to 
examine Dicer+/+ and Dicerd/d ovaries 1.5 days after coitus. The array 
Figure 2
Impaired angiogenesis in the CLs of Dicerd/d mice. (A) Ovarian tissue sections obtained from Dicer+/+ 
and Dicerd/d mice on day 1.5 of pregnancy were stained with H&E (original magnification, ×100). CLs in 
Dicer+/+ and Dicerd/d mice ovaries is denoted by the boxes and are shown at higher original magnifica-
tion (×400, bottom). The cells had less cytoplasm and less vascularity in the CLs of Dicerd/d mice. (B) 
Immunofluorescence analyses of ovaries from Dicerd/d and Dicer+/+ mice on day 1.5 of pregnancy show 
the localization of type IV collagen — a marker of the basal lamina of endothelial cells. Close examination 
of the vascular network in the CLs denoted by the boxes (top) is shown at higher magnification (×400; 
bottom). Dicer+/+ CLs showed more filamentous and punctuated collagen IV staining, which indicated 
higher vessel densities than those in Dicerd/d mice. (C) PECAM (CD31) immunofluorescence staining of 
CLs in Dicerd/d and Dicer+/+ mice on day 1.5 of pregnancy. The number and the length of the vessels were 
greater and longer in Dicer+/+ CLs. Original magnification, ×400. (D) Cumulative vessel length in CLs was 
determined as the average of the number of vessels per 100 × 100 μm2 multiplied by the vessel length in 
3 random fields. The results of type IV collagen immunofluorescence staining from 4 different Dicer+/+ and 
Dicerd/d pairs were used. The data are expressed as mean ± SD. *P = 0.0012.
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analysis showed that, of the 24 angiogenesis-related proteins, the 
expression of an antiangiogenic factor, TIMP1, was more than 
2-fold greater in Dicerd/d mouse ovaries than in Dicer+/+ ovaries (Fig-
ure 3, A–C, and Supplemental Figure 2). The expression of plate-
let factor 4, another antiangiogenic factor, was also more than 
1.5-fold greater in Dicerd/d mouse ovaries. The expression of KDR 
(VEGFR2/Flk1) and Flt1 (VEGF1) mRNA have been reported to 
be elevated in Dicer-deficient whole embryos (7). However, we only 
detected a slight upregulation in Dicerd/d mouse ovaries (Supple-
mental Figure 3). In contrast, we confirmed the increase of TIMP1 
protein expression in Dicerd/d ovaries by western blot analysis (Fig-
ure 3D) and then decided to further 
address the mechanism of Dicer1 
deficiency–mediated enhancement 
of TIMP1 expression.
TIMP1 protein expression is targeted by 
miRNAs. Potential miRNA target sites 
in the 3′-UTR of mouse (mTIMP1 
were analyzed with bioinformatics 
programs using 2 different methods. 
With the first method, possible can-
didate miRNAs were selected by using 
the program MicroInspector (34) and 
then those miRNAs were confirmed 
one by one with rna22, a recently 
reported new miRNA binding site 
prediction program (35). With the 
second method, candidate miRNAs 
were simply selected by one well-
known prediction program, miRanda 
software (36). Both approaches pre-
dicted the same candidate miRNAs, 
miR17-5p and let7b, and, although 
the target positions revealed by the 
2 approaches were not exactly the 
same, they were mostly overlapping 
(Figure 4A). Primer extension analy-
ses revealed that miR17-5p and let7b 
are expressed in Dicer+/+ mouse ova-
ries and were not detected in Dicerd/d 
ovaries (Figure 4B).
To validate the effect of candidate 
miRNAs on TIMP1 expression, a 
reporter plasmid was constructed by 
fusing the 3′-UTR of mTIMP1 to the 
3′-UTR of a luciferase reporter gene, 
as was done by others (37). Transfec-
tion with the expression vector of 
miR17-5p and/or let7b, but not an 
unrelated miRNA, miR378, resulted 
in a 35%–55% decrease in reporter 
activity (Figure 4C). To further con-
firm the effect of candidate miRNAs 
on TIMP1 expression, TIMP1 expres-
sion plasmids containing full-length 
TIMP1 cDNA were transfected into 
293T cells together with various 
miRNA expression plasmids. The 
expression of TIMP1 was repressed 
by the coexpression of miR17-5p 
and/or let7b, which was accompanied by decreased TIMP1 activi-
ties in reverse zymography using active MMP2-containing gels 
(Figure 4D). These results suggest that TIMP1 expression can be 
regulated by miR17-5p and let7b. We found no additive or syner-
gistic effects of these 2 miRNAs, probably because the target sites 
of these 2 miRNAs mostly overlapped (Figure 4A).
miR17-5p and let7b regulate the endothelial cell angiogenic function in vitro. 
Because TIMP1 is known to be expressed in endothelial cells and to 
have a negative influence on the endothelial cell angiogenic phe-
notype (38–40), a simian virus 40-transformed mouse endothelial 
cells (SVEC4-10, or SVEC) was used to examine the relationship 
Figure 3
TIMP1 expression is elevated in Dicerd/d female mice ovaries. (A) Mouse angiogenesis-related anti-
body arrays hybridized with ovarian lysates from Dicer+/+ and Dicerd/d mice on day 1.5 after coitus. 
Two independent experiments using different Dicer+/+ and Dicerd/d littermate mice pairs were per-
formed. A representative image is shown. The positions of TIMP1 are denoted by boxes and arrows. 
The positive loading controls are also denoted by boxes and arrows. The map of antibodies spot-
ted on these arrays is shown below. (B) Signal intensity ratios of each gene between Dicer+/+ and 
Dicerd/d mice ovaries obtained by protein array analyses. The normalized signal intensities of each 
protein from Dicerd/d mice ovaries were divided by those from Dicer+/+ mice ovaries. Four values 
for each gene obtained from 2 independent experimental sets were used for the analysis. The data 
are expressed as mean ± SD. Genes with low signal intensity that could not be analyzed further are 
expressed as N.D. (not determined). The mean signal intensities of TIMP1 in Dicerd/d mice ovaries are 
more than 2-fold those in Dicer+/+ mice. (C) The distribution of log10 conversion values of the average 
of normalized signal intensities (n = 4) from each protein is shown as a scatter plot. The solid lines 
indicate the position of 2-fold changes in the intensities. The results for TIMP1 and platelet factor 4 
are indicated by arrows. (D) Verification of Dicer1 protein deficiency and TIMP1 protein upregulation 
in Dicerd/d mice ovaries. Dicer1 and TIMP1 protein expression in the ovaries of 2 separate Dicerd/d and 
Dicer+/+ littermate mice on day 1.5 after coitus are shown. GAPDH was used as a loading control.
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between the TIMP1-targeting miRNAs and endothelial cell angio-
genic function in vitro. Because one of the most specific tests for in 
vitro approximation of angiogenesis is the measurement of the abil-
ity of endothelial cells to form 3-dimensional structures (tube for-
mation) (41), we examined the tube formation by SVEC placed on 
Matrigel. The inhibition of miR17-5p and let7b by complementary 
2′-O-methyl oligonucleotides in SVEC significantly impaired tube-
forming activity (Figure 5A). In contrast, overexpression of miR17-
5p and let7b significantly increased endothelial tube formation 
(Figure 5A). The statistical significance of the effect of inhibiting 
or increasing miR17-5p and let7b in SVEC on tube formation 
was determined by measuring tube length 12 and 18 hours after 
seeding on Matrigel (Figure 5B). The expression of miR17-5p and 
let7b in SVEC was confirmed by primer extension analyses (Figure 
5C). The change in tube-forming activity was not dependent on 
the change in cell proliferation or cell motility, because they were 
not affected by the transfection of miRNA inhibitors or precursors 
(Figure 5, D and E). In contrast, the levels of TIMP1 activity against 
MMP2 activity changed after transfection with miRNA inhibitors 
or precursors (Figure 5F). These results suggest that miR17-5p and 
let7b are important for the angiogenic activity of endothelial cells 
through the modulation of TIMP1 and MMP activities.
In vivo miRNA injection restores angiogenesis in the CL of Dicerd/d female 
mice. To evaluate the role of miR17-5p and let7b on CL angiogene-
sis in vivo, these miRNAs were injected into Dicerd/d mouse ovaries. 
We tried to inject miRNAs into ovarian medulla tissues directly; 
however, in this case, female mice did not accept mating, typically 
for more than 3 weeks after treatment, probably because of the 
damage or stress of the ovaries associated with the procedure. In 
another attempt, the transfection reagent mixture was injected 
into the ovarian bursa, which resulted in the ovary floating in the 
transfection complex to be covered with ovarian bursa. To deter-
mine the transduction efficiency of this technique, fluorescence-
labeled RNA oligonucleotides were used as a marker. Three days 
after transfection, the ovaries in the frozen section were examined 
under a fluorescent microscope. The labeled RNA was distributed 
in the whole treated ovaries, although there was an inconsistency 
in the transduction efficiency among different cell type compo-
nents (Figure 6A). Next, miRNAs were transfected into one ovary 
in each Dicerd/d female mouse and, as a control, only transfection 
reagents were injected in the other ovary. On the next day of the 
treatment, the mice were housed with fertile males, and they typi-
cally mated within 5 days of treatment. The patterns of a marker 
of the basal lamina of endothelial cells — type IV collagen — in the 
CLs were found to be more filamentous and punctuated in the 
miRNA-introduced ovaries than were those in the control ovaries 
1.5 days after coitus, and cumulative vessel length in the CLs was 
also recovered (Figure 6, B and C, and Supplemental Figure 4). 
Consistent with this, TIMP1 expression in the miRNA-injected 
ovaries was indeed suppressed 1.5 days after coitus (Figure 6D). 
The suppression of TIMP1 expression after miRNA injection was 
also confirmed by antibody arrays using the ovaries 1.5 days after 
coitus (Figure 6E and Supplemental Figure 5). Moreover, serum 
progesterone values in Dicerd/d mice with the exogenously intro-
duced miRNA precursors into both ovaries were also partially 
recovered, at least until day 5.5 of pregnancy (Figure 7C). These 
Figure 4
miR17-5p and let7b can target 3′-UTR of mTIMP1. (A) 
miRNA target positions in the 3′-UTR of mTIMP1 were iden-
tified by computational prediction methods, MicroInspector, 
and miRanda. The same candidate miRNAs, miR17-5p and 
let7b, were predicted by the different programs; however, 
the predicted miRNA-targeting sequences in the 3′-UTR 
of TIMP1 are not exactly the same. (B) Primer extension 
analyses showed the expression of the indicated miRNAs 
in Dicer+/+ and Dicerd/d mice ovaries. NC, negative control. 
(C) miR17-5p and let7b can target 3′-UTR of TIMP1. The 
293T cells were transiently transfected with a reporter plas-
mid (pLuc-TIMP3′-UTR) with or without indicated miRNA 
expression plasmids, and 36 hours after transfection, a 
reporter assay was performed. The relative luciferase val-
ues were calculated by dividing firefly luciferase values 
with internal control renilla luciferase values. The value 
from the negative control was set at 1. Data are shown as 
mean ± SD from 3 independent experiments. *P = 0.032, 
**P = 0.00082, ***P = 0.0035. (D) miR17-5p and let7b down-
regulate TIMP1 expression and activity. The 293T cells were 
transiently transfected with pcDNA-TIMP1, with or without 
the indicated miRNA expression plasmids, and pRL-TK. 
TIMP1 expression was examined by western blotting 36 
hours after transfection (top). Cell extracts were normalized 
based on the luciferase value of cotransfected pRL-TK to 
avoid the variances of transfection efficiency. Bottom: Result 
of reverse zymography using the MMP2-containing gels 
and the concentrated culture supernatant collected from the 
transfected cells to quantitate the activities of TIMP1 against 
MMP2 activities. A representative result from 4 independent 
experiments is shown. Numbers below the images refer to 
the fold changes of the intensities.
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results suggest that miR17-5p and let7b can partially recover the 
vascularity in the CLs, likely in part through the suppression of 
TIMP1 expression in Dicerd/d mouse ovaries.
In contrast, transduction of anti-miRNA inhibitors into Dicer+/+ 
mouse ovaries resulted in decreased vessel development in CLs 
(Figure 7A) with upregulation of TIMP1 expression in the ovaries 
(Figure 7B). Dicer+/+ mice in which anti-miRNA inhibitors were 
exogenously introduced into both ovaries also showed a decrease 
in serum progesterone levels and could not maintain their preg-
nancy. However, this failure was not considered to be solely due 
to the effects of anti-miRNA inhibitors, because Dicer+/+ mice 
injected only with transfection reagents also showed decreased 
progesterone levels after day 5.5 of pregnancy and could not 
maintain their pregnancy (Figure 7C). The failure to maintain 
pregnancy may have been due to the nonspecific effects associ-
ated with the injection and transfection procedure. Nonetheless, 
anti–miR17-5p and let7b inhibitors upregulated TIMP1 expres-
sion in the ovaries, decreased vascularity in the CLs, and decreased 
serum progesterone values in Dicer+/+ mice during an earlier phase 
of their pregnancy.
Similarly, although the introduction of miR17-5p and let7b 
improved the vascularity of the CLs, as well as the serum pro-
gesterone levels of Dicerd/d mice, none of these mice maintained 
their pregnancy to a later phase. The most likely explanation 
was the possible requirement of many other miRNAs during the 
process of pregnancy, such as the participation of unidentified 
miRNA(s) that target some other angiogenesis-related factor(s), 
or the involvement of some unknown miRNAs in the devel-
opment during the later phase, such as placental formation. 
Therefore, injection of just 2 miRNAs could not fully restore 
Figure 5
miR17-5p and let7b control endothelial 
cell angiogenic function. (A and B) 
Indicated anti-miRNA oligonucleotides 
or miRNA precursors were transfected 
into SVEC. Thirty-six hours after trans-
fection, cells were seeded on Matrigel. 
Tube length was quantified after 12 and 
18 hours. Representative micrographs 
(A) and statistical summary (B) are 
shown. Data represent mean ± SD of 3 
experiments. *P = 0.0014, **P = 0.0057, 
***P = 0.000055, ****P = 0.00067. (C) 
Primer extension analyses determined 
the expression of the indicated miRNAs 
in SVEC. (D) miR17-5p and let7b had 
no effect on the proliferation of SVEC. 
Thirty-six hours after transfection of 
the indicated oligos into SVEC, 5 × 104 
cells were seeded, and the number of 
cells was determined by cell counting 
at the indicated time points. Data are 
presented as mean ± SD (n = 4 per 
group, P = NS). (E) miR17-5p and let7b 
had no effect on the motility of SVEC. 
In vitro wound healing was quantified 
as the average length of the elongation 
of wound edges at 4 specific points 
over 24 hours. Data are presented as 
mean ± SD (n = 3 per group, P = NS). 
(F) The activities of TIMP1 against 
MMP2 were modulated by miRNAs. A 
representative result of reverse zymog-
raphy is shown using the the SVEC cul-
ture supernatant after transfection with 
the oligos (lane 1, control antisense; 
lane 2, anti–miRNA17-5p and let7b; 
lane 3, control miRNA precursors; lane 
4, miR17-5p and let7b precursors). The 
numbers indicate the fold changes of 
the band intensities. GAPDH expres-
sion did not change after transfection of 
oligos. The experiments were repeated 
3 times with similar results.
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all processes necessary to maintain pregnancy. Other possible 
explanations were as follows: the amounts of miR17-5p and 
let7b introduced into the ovaries of these mice were insufficient, 
the transfected miRNAs might not last very long in vivo, and 
the nonspecific physiological and/or endocrine stress directly 
derived from the procedure and subsequent wound healing 
might affect the course of pregnancy, as was observed in anti-
miRNA inhibitor transduced Dicer+/+ mice. Nevertheless, we 
concluded that diminished miRNA production in Dicerd/d mice 
impairs CL angiogenesis.
Discussion
The study described in this article indicates that the function of 
the ovary is tightly regulated by miRNA, because the most obvi-
ous effect of the hypomorphic Dicer1 mutation is ovary dysfunc-
tion–mediated female infertility. Mammalian reproduction is a 
multistep process, including folliculogenesis, oocyte maturation, 
ovulation, fertilization, cleavage, implantation, and maintenance 
of pregnancy (42–44). Although oocytes cannot mature without 
Dicer1 (27, 28), our data show that a reduction in Dicer1 expres-
sion only affected implantation and the maintenance of pregnancy. 
Figure 6
miR17-5p and let7b recover the vascularity in the CLs in Dicerd/d mouse ovaries in vivo. (A) Cy-3–labeled siRNA was injected into the ovarian 
bursa. Injection of transfection reagent alone was used as control. Top: Images in the bright field. Bottom: Same fields in the fluorescent phase. 
Original magnification, ×100. (B) miR17-5p and let7b recover the vascularity in CLs. miRNA precursors were injected into the ovarian bursa of 
Dicerd/d mice, and ovaries were stained with anti–type IV collagen, as described in Methods. Top: original magnification, ×100. Close examina-
tion of the vascular network denoted by the boxes are shown (original magnification, ×400; bottom). (C) Cumulative vessel length in CLs in 
the miRNA-injected ovaries [(d/d) + miR precursor injection] and the corresponding control ovaries (d/d) was determined as described in the 
legend of Figure 2D. Results are from 3 different Dicerd/d mice. Data represent mean ± SD. *P = 0.0031. (D) miR17-5p and let7b suppressed the 
expression of TIMP1 in the ovaries in vivo. miRNA precursors were injected into the ovaries as described in Methods. TIMP1 protein expression 
in the ovaries of 2 separate miRNA-injected mice are shown. SVEC lysates were used as a positive control. GAPDH was used as a loading 
control. (E) The suppression of TIMP1 expression in the ovary was confirmed by an antibody array. Signal intensity ratios of each gene between 
the miRNA-introduced Dicerd/d ovaries (d/d + miR injection) and the corresponding control Dicerd/d ovaries (d/d) are shown after normalization. 
Results are the summary of 4 values of each gene from 2 independent experiments using different mice.
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The defect in the growth of new capillary vessels in the CLs 
was at least part of the mechanism underlying the CL insuf-
ficiency found in Dicerd/d mice. Although we used TIMP1 to 
determine the role of miR17-5p and let7b in CL development, 
other miRNA-regulated proteins may also participate in CL 
angiogenesis and, thus, other unknown miRNAs may also be 
important to CL functioning. Several miRNAs have been impli-
cated in the control of various angiogenesis-related molecules 
and thus they may positively or negatively affect angiogen-
esis in a system-dependent manner (16–19). Whether miRNAs 
are commonly involved in angiogenesis in the CL and other 
systems requires further investigation. Whereas miR17-5p 
and let7b are involved, CL insufficiency in 
Dicerd/d mice should be the net consequence 
of the global downregulation of miRNAs.
It should be noted that our results do not 
exclude the possibility that other ovarian 
functions, such as folliculogenesis, oocyte 
maturation, ovulation, or other endocrine 
functions, are regulated by miRNAs. How-
ever, our hypomorphic Dicer1 mutant mice 
showed that the development and func-
tion of the ovarian CL is the physiological 
process that appears to be most sensitive to 
miRNAs’ deficiency during the early phase 
of pregnancy.
Recent studies have shown that oocytes 
with Dicer1 deletion failed to progress 
through first cell division (27, 28). How-
ever, the oocytes of our Dicer1-deficient 
mice appeared to be normal in this pro-
cess, which suggested that the reduction in 
Dicer1 protein in Dicerd/d oocytes was still 
sufficient for oocyte maturation. Deletion 
of exon 1 and exon 2 of the Dicer1 gene 
impaired angiogenesis during embryonic 
development (7), whereas hypomorphic 
Dicer1 expression in our Dicerd/d mice did 
not affect angiogenesis during embryonic 
development, but did affect angiogenesis 
in the CL. This finding indicated that 
angiogenesis in different tissues has dif-
ferent sensitivities to Dicer1 protein levels. 
Because different miRNAs were identified 
as regulating angiogenesis in different sys-
tems (16–19), it is possible that these dif-
ferent sensitivities to Dicer1 protein levels 
are due, in part, to the different miRNAs 
involved in the angiogenesis within the CL 
and embryo.
Because the deletion of Dicer1 is embry-
onically lethal (6), live hypomorphic 
Dicer1 mutant mice should serve as a use-
ful system for analyzing Dicer1’s role in 
development- and health-related issues 
in adult animals. The existence of natural 
cases of total knockout of Dicer1 or total 
knockout of Dicer1 in certain tissues, sim-
ilar to the conditional knockout mice, are 
unlikely because Dicer1 is critical to sur-
vival. Studying the changes in Dicer1 expression or functional 
deficiency that result from single nucleotide polymorphisms 
or hypomorphic mutations in Dicer1 is potentially important 
in determining whether Dicer1 is involved in a given disease. 
It may be worth analyzing the expression and sequence of the 
Dicer1 gene in various angiogenesis-related diseases, especially 
in cases of female infertility, as shown here. This study demon-
strates that miRNAs can be involved in the pathogenesis of CL 
malfunction and may have therapeutic implications, not only 
for the control of fertility, but also for the treatment of ovarian 
disorders and other pathological conditions characterized by 
abnormal angiogenesis.
Figure 7
Anti–miR17-5p and let7b oligonucleotides impaired the vascularities in the CLs in Dicer+/+ 
mouse ovaries. (A) A mixture of anti–miRNA17-5p and let7b oligonucleotides and transfec-
tion reagent, or transfection reagent only, were injected into the right or left ovarian bursa of 
Dicer+/+ mice, respectively, and the patterns of type IV collagen in the CLs were examined 
as described in the legend of Figure 6B. A representative result from 3 independent mice is 
shown. (B) Anti–miR17-5p and let7b oligonucleotides enhanced the expression of TIMP1 in the 
ovaries in vivo. TIMP1 protein expression in the ovaries of mice injected with 2 anti–miR17-5p 
plus anti-let7b oligonucleotides. SVEC lysates were used as positive control for the detection 
of TIMP1. GAPDH was used as a loading control. (C) Serum progesterone levels were modi-
fied in miRNA precursors or anti-miRNA inhibitor–injected mice. Dicerd/d mice injected with a 
mixture of miRNA17-5p and let7b precursors into both side ovaries [(d/d) + miRNA precursors] 
had greater serum progesterone levels than did Dicerd/d mice (d/d) until day 5.5 of pregnancy. 
In contrast, Dicer+/+ mice injected with a mixture of anti–miRNA17-5p and let7b inhibitors into 
both ovaries [(+/+) + miRNA inhibitors] had lower serum progesterone levels than did Dicer+/+ 
mice (+/+). The serum progesterone levels of Dicer+/+ mice injected only with transfection 
reagents into both side ovaries are also shown [(+/+) + mock]. Serum progesterone levels were 
determined by ELISA on days 1.5, 3.5, 5.5, and 7.5 of pregnancy and expressed as mean ± SD 
(n = 3 in each group). A graph of results until day 5.5 is shown in the inset.
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Methods
Experimental animals. Dicer-deficient mice (129/Ola and C57BL/6 mixed 
background), obtained using a gene-trap method, were described previ-
ously (13). The mice used in this study were female offspring littermates 
derived from crosses between male and female Dicer+/d mice after more than 
10 generations of sibling breeding (13). All experiments were carried out in 
compliance with the rules of, and were approved by, the Animal Use Com-
mittee of The Scripps Research Institute.
Timed mating experiments. For timed mating experiments, Dicer+/+ and 
Dicerd/d female mice were bred with fertile wild-type males. To induce 
superovulation, mice were first injected (i.p.) with pregnant mare’s serum 
gonadotropin (5 IU/mouse; Sigma-Aldrich) and then with human chori-
onic gonadotropin (5 IU/mouse; Sigma-Aldrich) 48 hours later. The female 
mice were then bred with male mice overnight. The following morning 
(day 0.5 after coitus), the female mice were checked for a vaginal plug. The 
mice were sacrificed on day 1.5. Oocytes and 2- and 4-cell stage embryos, 
collected by flushing the oviducts with PBS, were examined under a dis-
secting stereomicroscope.
Ovary transplantation. Ovary transplantation was performed as described 
previously (45) using 4- to 6-week-old female littermate mice to avoid 
immunological rejection of tissues. After anesthesia with ketamine, a dor-
solateral incision about 1.0 cm long was made in the lumber region on each 
side of the midline. Through the incision, the ovaries were gently pulled 
outside the body. The ovarian bursa was cut to make a small incision at 
the opposite side of the oviduct. The ovaries were removed by cutting the 
ovarian stalk with scissors. After the bleeding stopped, donor ovaries were 
transplanted into the empty bursas of each recipient mouse. The bursas 
were placed back, and the reproductive tract was returned to the abdomi-
nal cavity. The skin incision was closed with sutures. Two weeks after the 
operation, treated mice were mated with fertile male mice. The genotype of 
the offspring born to the recipient mice was confirmed by PCR (13).
Histological analysis, immunohistochemistry, and immunofluorescence. Tis-
sues were dissected out, fixed with 4% paraformaldehyde, embedded in 
paraffin, sectioned, and analyzed by H&E staining. For type IV collagen 
immunofluorescent studies, sections were stained with primary anti–
type IV collagen (Abcam) and secondary Alexa Fluor 488–conjugated 
goat anti-rabbit IgG antibodies (Molecular Probes). For CD31/PECAM 
immunofluorescent studies, frozen sections were incubated with primary 
anti-CD31/PECAM (MEC 13.3; BD Pharmingen) and then with second-
ary Alexa Fluor 594–conjugated goat anti-rat IgG antibodies (Molecular 
Probes). Slides were mounted using VectaShield (Vector Labs). Cumula-
tive vessel length in CLs was evaluated as the average of the number of 
vessels per 100 × 100 μm2 multiplied by the vessel length in 3 random 
fields at ×400 fields from 4 different pairs.
Angiogenesis-related protein antibody array. Mouse Lysate Angiogenesis 
Antibody Array, which detects 24 different kinds of angiogenesis-related 
cytokines, was purchased from Chemicon. Dicer+/+ and Dicerd/d mouse ova-
ries, day 1.5 after coitus, were used for the screening according to the man-
ufacturer’s instructions. The data were evaluated using FluorChem8900 
software (Alpha Innotech). A grid containing a series of circles correspond-
ing to the spots of the array was laid over the image, and the circles were 
adjusted to each spot. The intensities within the circle were calculated, and 
the local background intensities around the circle (intensities in the outer 
torus with 1.3-fold longer diameter of the spot circle) were subtracted to 
reduce bias. Genes whose signal intensities were lower than 5 times their 
background intensities were excluded from further analyses to exclude 
the variability due to their low expression levels. The normalized signal 
intensities of each gene were determined as the intensities divided by the 
average intensities of positive control spots on the same array. Relative pro-
tein expression levels between different samples were determined as signal 
intensity ratios, obtained by dividing the normalized signal intensities of 
each gene from different samples. Because each gene has 2 spots on one 
array, 4 values for each gene derived from 2 independent experimental sets 
were used for one statistical analysis. A scatter plot was depicted using log10 
conversion of the average of normalized signal intensities of each gene.
Primer extension.	Primer extension was performed as described previously 
(5). The primer sequences of miR17-5p and let7b are ACTACCTGCACTG-
TAAGC and AACCACACAACCTACTAC, respectively.
Prediction of miRNA target sites.	Two computational miRNA target pre-
diction programs, MicroInspector (34) and miRanda (36), were used to 
predict miRNA binding sites in 3′-UTR mTIMP-1 sequences. MicroIn-
spector was run with the hybridization temperature set to 37°C, and 
the free-energy cutoff was set to –22 kcal/mol. Of the primary candidate 
miRNA sequences, those miRNAs that were confirmed by another pro-
gram as rna22 (35) were selected as candidates. miRanda was run accord-
ing to the authors’ recommendation.
Reporter plasmids and reporter assay.	 The vector pSPORT1-mTIMP1, 
which contains full open reading frame sequences of mTIMP1 (IMAGE 
ID: 30056565), was purchased from ATCC. The reporter plasmid was 
constructed by subcloning PCR-amplified 3′-UTR fragments from the 
pSPORT-mTIMP1 into the downstream of a Photinus pyralis (firefly) lucif-
erase reporter gene using EcoR1 and Kpn1 sites. To check the transfection 
efficiency, pRL-TK, a control plasmid (Promega), was used. Transfection was 
performed using Lipofectamine 2000 (Invitrogen). Luciferase assays were 
carried out with the Dual-Luciferase Reporter Assay System (Promega).
Expression plasmids.	pcDNA3-TIMP1 expression vector was constructed by 
subcloning PCR-amplified coding sequence fragments from the pSPORT-
mTIMP1 with EcoR1 and Kpn1 sites. pSuper-miR378, pSuper–miR17-5p, 
and pSuper-let7b, which express miR378, miR17-5p, and let7b, respectively, 
were constructed by cloning the miR sequences into the pSuper vector using 
XhoI and BglII sites.
Western blotting analysis and antibodies.	The cell extracts and homogenized 
mouse tissues were normalized for protein concentration using the Bio-
Rad Dc Protein Assay Kit (Bio-Rad), or, for the detection of TIMP1 in the 
overexpression of miRNA, cell extracts were normalized based on the lucif-
erase value of cotransfected pRL-TK to avoid the variances of transfection 
efficiency. Protein (30 μg) was resolved by SDS-PAGE, transferred to PVDF 
(Hybond-P; Amersham Pharmacia Biotech), and immunoblotted. A goat 
polyclonal antibody against mTIMP1 was purchased from R&D systems. A 
rabbit monoclonal anti-VEGF receptor 2 antibody (55B11) was purchased 
from Cell Signaling. A mouse monoclonal anti-VEGF receptor 1 (Flt-1) 
antibody (MAB1664) and a mouse anti-GAPDH antibody were purchased 
from Chemicon. The bound antigens were detected using SuperSignal 
West Femto Maximum Sensitivity Substrate (Pierce).
Cells.	The	mouse endothelial cell line SVEC4-10 and the human embry-
onic kidney cell line 293T were obtained from ATCC and cultured in 
DMEM supplemented with 10% FBS.
Reverse zymography.	SVEC or 293T cell culture supernatant after trans-
fection of the TIMP1 expression vector with miRNA expression plasmids 
anti-miRNA oligos, or miRNA precursors were analyzed for the activity of 
TIMP1 and MMP2 as described previously (46). Because MMPs are sepa-
rated from their inhibitor TIMP1 during the normal zymographic proce-
dure, their activities cannot be analyzed accurately. To avoid this problem 
and better define the balance existing between MMP2 and its inhibitor 
TIMP1, we measured the TIMP1 activity by reverse zymography. Briefly, 36 
hours after transfection (control antisense oligos with random sequences, 
anti–miR17-5p and let7b oligonucleotides, control miRNA precursors 
with random sequences, or double-stranded miR17-5p and let7b precur-
sors), supernatants were collected, concentrated 10-fold using the Centri-
con concentrator (Amicon), and electrophoresed on nondenaturing 0.1% 
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SDS, 12% polyacrylamide gels containing 1 mg/ml gelatin, and 0.16 μg/ml 
4-aminophenylmercuric acetate–activated MMP-2 (both from EMD). Elec-
trophoresis was carried out at 4°C, and then the gel was renatured in 2.5% 
Triton X-100 for 3 hours with 3 times replacement of fresh solution at 
room temperature. Then, the gel was incubated in enzyme buffer (50 mM 
Tris, pH 7.5, 200 mM NaCl, 5 mM CaCl2, and 0.02% Brij-35) for 24 hours at 
37°C and stained with Coomassie blue G-250. The gel image and the inte-
grated intensities were obtained and quantified using FluorChem8900.
Endothelial tube formation assay, cell proliferation assay, and migration assay.	Anti–
miRNA17-5p and let7b oligonucleotides, double-stranded miRNA17-5p, 
and let7b precursors and random-sequence anti-miRNA oligos and 
miRNA precursors were purchased from Ambion; 40 nM anti-miRNA 
oligos or 40 nM miRNA precursors were transfected into SVEC. Control 
antisense oligos with random sequences and control miRNA precursors 
with random sequences were used as negative controls. Thirty-six hours 
after transfection, 1 × 105 cells were seeded in a 12-well plate coated with 
200 μl Growth Factor Reduced Matrigel (BD Biosciences). Tube length was 
quantified after 12 and 18 hours by measuring the cumulative tube length 
in 3 random microscopic fields with a computer-assisted microscope 
using the program AxioVision 3.1 (Carl Zeiss). For the cell proliferation 
assay, 36 hours after transfection, 5 × 104 cells were seeded and the num-
ber of cells was determined by cell counting at the indicated time points. 
For the examination of cell motility, an in vitro wound healing assay was 
performed. Transfected cells were seeded with 2.5 × 106 cells in a 12-well 
plate and cultured in 1% FBS for 24 hours to synchronize and were then 
wounded by removing a 200- to 400-mm strip of cells across the well with 
a 200-μl pipette tip. Wound healing was quantified as the average length of 
the elongation of wound edges over 24 hours by using AxioVision 3.1.
Progesterone assay.	Serum progesterone levels were measured in serum 
samples collected at indicated days after coitus using a rodent progester-
one ELISA kit according to the manufacturer’s instruction (Endocrine 
Technologies Inc.). The limit of sensitivity of the assay was 0.1 ng/ml.
Semiquantitative RT-PCR analysis.	Total RNA was extracted from ovaries 
using Trizol reagent (Invitrogen), and RT-PCR was done as described pre-
viously (13). The primers used were as follows: cytochrome P450 family 
11 subfamily a polypeptide 1, 5′-AGAAGCTGGGCAACATGGAGTCAG-3′ 
and 5′-TCACATCCCAGGCAGCTGCATGGT-3′; luteinizing hormone 
receptor, 5′-CTTATACATAACCACCATACCAG-3′ and 5′-ATCCCAGC-
CACTGAGTTCATTC-3′; prolactin receptor, 5′-ATACTGGAGTAGAT-
GGGGCCAGGAGAAATC-3′ and 5′-CTTCCATGACCAGAGTCACTGT-
CAGGATCT-3′. The result was quantified using FluorChem software and 
normalized by GAPDH intensities.
miRNA injection technique.	Mice were anesthetized using ketamine. A 
dorsolateral small incision was made in the lumber region on each side 
of the midline. Through the peritoneal incision, the ovaries were gently 
pulled outside the body. The intrabursal injection was performed under 
microscopic magnification by inserting a 30-gauge needle through the 
ovarian fat pad into the ovarian bursa. The ovaries were returned to the 
abdominal cavity, and the wound was sutured with 4-0 silk (Ethicon Inc.). 
For histological analyses, 5 female Dicerd/d mice were used. In each mouse, 
a 50-μl mixture of 0.5 nmol double-stranded miRNA17-5p and let7b pre-
cursors with normal saline and lipofectamine 2000 was delivered into 
the right ovary, and transfection reagents alone were injected into the 
left ovary as a control. To examine the course of pregnancy, 5 Dicerd/d 
female mice were injected with miRNAs into both ovaries. To determine 
the injection and transfection efficiency, Cy-3–labeled, fluorescent siRNA 
(siGLO; Dharmacon) was injected in the same way. Injection of transfec-
tion reagent alone was used as control. Three days after the procedure, the 
ovaries were sectioned, frozen, and examined under a fluorescent micro-
scope. Mice were initially housed separately; when they resumed nor-
mal behavioral activity, they were housed with a fertile male for mating. 
Vaginal plugs were confirmed the next morning (day 0.5 of pregnancy). 
For the histological analyses, mice were sacrificed on day 1.5, and the 
ovaries were sectioned, frozen, and then examined histologically. Western 
blotting of TIMP1 and the antibody analyses were performed using the 
lysates of control, and the injected ovaries were extracted on day 1.5 of 
pregnancy. For the analyses of serum progesterone levels, serum samples 
were collected on the indicated days of pregnancy from 4 Dicerd/d mice 
in which both ovaries had been injected. In the case of Dicer+/+ mice, the 
same methods were used, except that anti–miRNA17-5p and let7b oligos 
were used instead of miRNA precursors.
Statistics.	The statistical significance of any differences was determined using 
the 2-tailed Student’s t test or Welch’s t test when variances were unequal.
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